GENETIC CHARACTERIZATION OF ALPORT SYNDROME
阿尔波特综合征的遗传特征
基本信息
- 批准号:3239217
- 负责人:
- 金额:$ 16.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 1992-02-29
- 项目状态:已结题
- 来源:
- 关键词:DNA Goodpasture's syndrome autosomal dominant trait biopsy chromosome deletion congenital deafness gel electrophoresis genetic counseling genetic disorder genetic disorder diagnosis genetic mapping genetic markers genetic transcription genotype glomerulonephritis human population genetics kidney transplantation linkage mapping major histocompatibility complex molecular pathology nephritis nucleic acid probes nucleic acid sequence sex chromosomes skin
项目摘要
Alport syndrome (AS) denominates a heterogeneous group of
hereditary chronic progressive glomerulonephritides that are
characterized by similar nephrologic symptoms and by similar
progressive degeneration of glomerular capillary epithelial
basement membranes (GBM). The etiology of AS is unknown but
is thought to involve defects of GBM structural proteins. Disease
frequency is greater than or equal to 1 in 5,000. Most affected
males experience end-stage renal disease (ESRD), and they
account for 2-4% of males that receive dialysis or kidney
transplantation. Phenotypic heterogeneity of AS among different
kindreds includes eye defects, thrombocytopathia, and/or
progressive sensorineural deafness, and rate of progression of
renal failure. Genotypic heterogeneity is reported to include
autosomal as well as the more clearly established X-linked
inheritance. The long-term objective of this application is to
determine the genetic and biochemical bases of AS in order that
specific and effective treatments or prevention might be
developed. We propose to better define the phenotypes, and to
use linkage of nephritis to X-linked restriction fragment length
polymorphic markers (RFLPs) to precisely map the chromosomal
locus for each of three X-linked AS phenotypes found among 23
Utah kindreds. We have already shown that two types of AS
among the three largest Utah kindreds are loosely linked to DNA
probes in the middle of the long arm of the X chromosome. We
propose to construct a high-resolution genetic linkage map of this
region of the X with currently available probes and ones we plan
to develop. By mapping the AS gene(s) within this genetically
well-defined region, we expect to test the hypothesis of genetic
heterogeneity for X-linked AS, to improve the process of genetic
diagnosis and counseling for this disease, and to develop an
approach to the identification and cloning of the defective
gene(s). We also propose to determine whether X-chromosome
deletions cause AS: the existence of deletions would improve the
prospects for rapid identification of the normal gene(s) that are
missing in AS.
Alport综合征(AS)是一组异质性的
遗传性慢性进行性肾小球肾炎,
以相似的肾病症状和相似的
肾小球毛细血管上皮进行性变性
基底膜(GBM)。 AS的病因不明,
被认为涉及GBM结构蛋白的缺陷。 疾病
频率大于或等于1/5000。 影响最大
男性患有终末期肾病(ESRD),他们
占接受透析或肾脏治疗的男性的2-4%
移植 不同人群AS的表型异质性
运动障碍包括眼缺陷、血小板增多症和/或
进行性感音神经性耳聋,
肾衰竭 基因型异质性包括
常染色体以及更明确的X连锁
传承 本申请的长期目标是
确定AS的遗传和生化基础,以便
具体和有效的治疗或预防可能是
开发 我们建议更好地定义表型,
利用肾炎与X-连锁限制性片段长度的连锁
多态性标记(RFLP),以精确定位染色体
在23个X连锁AS表型中,
来自犹他州的肯塔基州。 我们已经证明了两种类型的AS
犹他州三个最大的家族与DNA有着松散的联系
在X染色体长臂中间的探针。 我们
建议构建一个高分辨率的遗传连锁图,
X的区域与目前可用的探测器和我们计划
发展。 通过绘制AS基因的遗传图谱,
明确的区域,我们希望测试遗传的假设,
X连锁AS的异质性,以改善遗传过程
诊断和咨询这种疾病,并制定一个
鉴定和克隆缺陷的方法
基因。 我们还建议确定X染色体是否
缺失导致AS:缺失的存在会改善
快速鉴定正常基因的前景,
在AS失踪
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CURTIS L ATKIN其他文献
CURTIS L ATKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CURTIS L ATKIN', 18)}}的其他基金
相似海外基金
IMMUNOSUPPRESSION AND PLASMAPHERESIS IN GOODPASTURE'S SYNDROME
Goodpasture 综合征中的免疫抑制和血浆去除术
- 批准号:
4689968 - 财政年份:
- 资助金额:
$ 16.41万 - 项目类别:
IMMUNOSUPPRESSION AND PLASMAPHERESIS IN GOODPASTURE'S SYNDROME
Goodpasture 综合征中的免疫抑制和血浆去除术
- 批准号:
3964768 - 财政年份:
- 资助金额:
$ 16.41万 - 项目类别:














{{item.name}}会员




